Clinical trial
Mental Health Consequences of COVID19 Infection in the French Rheumatic Musculoskeletal Diseases (RMD) Cohort
NCT04510467 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mental Health Consequences of COVID19 Infection in the French Rheumatic Musculoskeletal Diseases (RMD) Cohort
- Lead sponsor
- University Hospital, Lille
- Phase
- Observational
- Overall status
- Terminated
- Start date
- January 20, 2021
- Completion date
- May 19, 2022
- Enrollment
- 296 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
auto inflammatory diseases, covid19, inflammatory rheumatism, systemic autoimmune disease